A Study of Breathing Sound-based Classification of Patients With Breathing Disorders
Huai'an First People's Hospital
1 other identifier
observational
200
1 country
1
Brief Summary
Sleep-disordered breathing can damage the cardiovascular system, and may also lead to dysregulation of the autonomic nervous system, endocrine disorders, and hemodynamic changes, causing multi-system and multi-organ damage. Screening for potential central-type patients among patients with respiratory disorders can help provide scientific diagnosis and treatment decisions, thus achieving precise treatment. Currently, research on the identification of sleep-disordered breathing phenotypes is in its infancy. Sleep-disordered breathing phenotypes, such as obstructive and central respiratory events, vary widely among individuals. Compared to indirect methods such as RIP and SpO2, changes in breathing sounds and snoring during sleep can more directly reflect airway obstruction. Different types of sleep-disordered breathing exhibit different characteristics in terms of snoring. Patients with obstructive sleep apnea experience narrowing or blockage of the airway due to relaxation of the throat muscles during sleep, which leads to breathing pauses and hypopnea events, resulting in decreased blood oxygen levels, arousal, and snoring. Central sleep apnea is caused by problems with the brainstem or respiratory control center, leading to breathing pauses. Snoring is usually not very prominent in patients with central sleep apnea. This study aims to screen for potential central-type patients by analyzing upper airway sounds of patients with sleep-disordered breathing, in order to achieve precise treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2021
CompletedFirst Submitted
Initial submission to the registry
May 2, 2023
CompletedFirst Posted
Study publicly available on registry
May 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedJune 13, 2023
June 1, 2023
2 years
May 2, 2023
June 10, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The accuracy of the binary classification of obstructive apnea and central apnea
Based on the binary classification of events, obstructive apnea is the negative class and central apnea is the positive class. Accuracy is the ratio of the predicted correct positive plus negative class to the total event.
3 days
The recall of the binary classification of obstructive apnea and central apnea
According to the binary classification of events, obstructive apnea is negative and central apnea is positive. Recall represents the proportion of all positive events in the dataset that the model correctly classifies as positive.
3 days
Secondary Outcomes (2)
The accuracy of the patient's apnea detection
3 days
The recall of the patient's apnea detection.
3 days
Other Outcomes (3)
The patient's sleep efficiency
3 days
The accuracy of hypoventilation detection in patients
3 days
The recall of hypoventilation detection in patients
3 days
Study Arms (1)
Group 1
Patients suspected of having obstructive apnea
Interventions
Polysomnography is mainly used to diagnose sleep breathing disorders, including sleep apnea syndrome, snoring, upper airway resistance syndrome, and also used for the auxiliary diagnosis of other sleep disorders, such as: narcolepsy, restless legs syndrome, insomnia classification, etc.
Eligibility Criteria
1. age between 18 to 75 yrs; 2. Patients diagnosed with apnea syndrome;
You may qualify if:
- the age of the patient is 18-75 years old;
- patients with confirmed PSG with AHI ≥ 5 times/hour, with or without daytime sleepiness, hypertension, and diabetes;
- sleep-disordered breathing has not been treated;
- informed consent of patients
You may not qualify if:
- pregnancy;
- have other diseases that are not suitable for participation in this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department Of Respiratory Medicine,Huai'an First People's Hospital,Nanjing Medical University
Huai'an, Jiangsu, 223300, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 3 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of respiratory Medicine in Huai'an No.1 People's Hospital
Study Record Dates
First Submitted
May 2, 2023
First Posted
May 22, 2023
Study Start
December 1, 2021
Primary Completion
December 1, 2023
Study Completion
June 1, 2024
Last Updated
June 13, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share